SPRO Chart
- 52-Week Range: $1.20 - $2.10
- Market Capitalization: $63.79M
- Short Percentage: 0%
- Target Price: $6.67
- Shares Outstanding: 52.72M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
SPRO released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Spero Therapeutics shares rise on FDA approval of pivotal complicated UTI trialProactive Investors | July 31st
- Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | June 30th
- Spero Therapeutics Appoints Sath Shukla as President & Chief Executive OfficerGlobeNewsWire | June 14th
- Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | May 31st
- Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | April 28th
- Spero Therapeutics: Massive Partnership Deal Still Not Properly Valued By The MarketSeeking Alpha | April 21st
- Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | March 31st
Company Info
Website: https://sperotherapeutics.com
Address: 675 Massachusetts Avenue, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 35
Address: 675 Massachusetts Avenue, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 35
$SPRO lmao wtf was that
$SPRO just fucking go already jeesh
$SPRO don’t be boring today beast
$SPRO strong move here
$SPRO hold
$SPRO no wonder price closed that way
$SPRO rocket fuel tanks are full. Gonna shoot to the stars
$SPRO looking good today??
$SPRO due for a spike!
$SPRO has just been halted from trading due to volatility.